SEC Company Response from Pathogenics, Inc. (CIK 0001320731) — Oct 3, 2005
Pathogenics, Inc. (CIK 0001320731)
Date: Oct. 3, 2005 · CIK: 0001320731 · Accession: 0001332277-05-000096
AI Filing Summary & Sentiment
File numbers found in text: 333-123431
Letter
PATHOGENICS, INC. 99 DERBY STREET, SUITE 200 HINGHAM, MA 02043 Telephone: (781) 556-1090 October 3, 2005 Ms. Mary K. Fraser, Esq. VIA FAX AT (202) 772-9217 Division of Corporate Finance ------------------------- United States Securities and Exchange Commission AND VIA EDGAR 450 Fifth Street, N.W. ------------- Washington, D.C. 20549 Phone: (201) 551-3609
RE: PATHOGENICS, INC. Form SB-2 Registration Statement File No. 333-123431
Dear Ms. Fraser:
Request is hereby made to accelerate the effectiveness of the above referenced registration statement to 2 p.m. eastern standard time, Wednesday, October 5, 2005, or as soon thereafter as practicable.
Pathogenics, Inc. (the "Company") hereby acknowledges that (i) should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; (ii) the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for adequacy and accuracy of the disclosure in the filing; and (iii) the Company may not assert this action as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Please direct any comments or questions to our counsel, David M. Loev, Attorney at Law, at (713) 524-4110.
Sincerely,
PATHOGENICS, INC.
------------------
Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
PATHOGENICS, INC.
99 DERBY STREET, SUITE 200
HINGHAM, MA 02043
Telephone: (781) 556-1090
October 3, 2005
Ms. Mary K. Fraser, Esq. VIA FAX AT (202) 772-9217
Division of Corporate Finance -------------------------
United States Securities and Exchange Commission AND VIA EDGAR
450 Fifth Street, N.W. -------------
Washington, D.C. 20549
Phone: (201) 551-3609
RE: PATHOGENICS, INC.
Form SB-2 Registration Statement
File No. 333-123431
Dear Ms. Fraser:
Request is hereby made to accelerate the effectiveness of the above
referenced registration statement to 2 p.m. eastern standard time, Wednesday,
October 5, 2005, or as soon thereafter as practicable.
Pathogenics, Inc. (the "Company") hereby acknowledges that (i) should the
Commission or the staff, acting pursuant to delegated authority, declare the
filing effective, it does not foreclose the Commission from taking any action
with respect to the filing; (ii) the action of the Commission or the staff,
acting pursuant to delegated authority, in declaring the filing effective, does
not relieve the Company from its full responsibility for adequacy and accuracy
of the disclosure in the filing; and (iii) the Company may not assert this
action as a defense in any proceeding initiated by the Commission or any person
under the federal securities laws of the United States.
Please direct any comments or questions to our counsel, David M. Loev,
Attorney at Law, at (713) 524-4110.
Sincerely,
PATHOGENICS, INC.
------------------
/s/ Frederic P. Zotos
------------------------------
Frederic P. Zotos
Chief Executive Officer and
Director
<PAGE>
</TEXT>
</DOCUMENT>